董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Lourdes Felix | 女 | Director | 58 | 8.92万美元 | 未持股 | 2026-09-04 |
| Stuart D. Porter | 男 | Director | 60 | 未披露 | 未持股 | 2026-09-04 |
| Geordan Pursglove | 男 | Chairman of the Board and Chief Executive Officer and Director and President | 37 | 166.73万美元 | 未持股 | 2026-09-04 |
| Jason Sawyer | 男 | Director | 54 | 8.18万美元 | 未持股 | 2026-09-04 |
| Michael Holloway | 男 | Director | 63 | 7.74万美元 | 未持股 | 2026-09-04 |
| Guy Primus | 男 | Director | 56 | 8.76万美元 | 未持股 | 2026-09-04 |
| John Travaglini | 男 | Director | 65 | 未披露 | 未持股 | 2026-09-04 |
| Chris McKay | 男 | Director | 52 | 未披露 | 未持股 | 2026-09-04 |
| Joaquin Aguerre | 男 | Director | 36 | 未披露 | 未持股 | 2026-09-04 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Bas van der Baan | 男 | Chief Scientific Officer | 54 | 17.40万美元 | 16.85 | 2026-09-04 |
| Geordan Pursglove | 男 | Chairman of the Board and Chief Executive Officer and Director and President | 37 | 166.73万美元 | 未持股 | 2026-09-04 |
| Peter Stazzone | 男 | Chief Financial Officer | 74 | 23.51万美元 | 未持股 | 2026-09-04 |
董事简历
中英对照 | 中文 | 英文- Lourdes Felix
-
Lourdes Felix，被任命为公司董事会成员，自2024年4月起生效。Felix女士是一位企业家和企业财务主管，在资本市场、公共会计和私营部门拥有30年的综合经验。她目前担任BioCorRx Inc.（OTCQB：BICX）的首席执行官、首席财务官以及董事会成员，该公司专注于成瘾治疗解决方案和相关疾病。自2012年10月起任职于BioCorRx。Felix女士是BioCorRx Pharmaceuticals Inc.的创始人之一和总裁，BioCorRx Pharmaceuticals Inc.是BioCorRx Inc.的控股子公司。在加入BioCorRx之前，她的工作经验是私营部门和公共会计。自2021年10月以来，Felix女士一直担任Siyata Mobile，Inc.（纳斯达克：SYTA）的董事会成员、独立董事、审计委员会主席以及薪酬委员会和提名与公司治理委员会成员。自2023年1月9日以来，Felix女士还一直担任Avalon GloboCare Corp.（纳斯达克：ALBT）的董事会成员、独立董事和薪酬委员会主席。Felix女士在财务、会计、全公司运营、预算编制和内部控制原则（包括GAAP、SEC和萨班斯-奥克斯利法案合规）方面拥有专长。她对联邦和州法规了如指掌，并成功管理和制作了SEC监管文件。她在发展和管理金融业务方面也有丰富的经验。Felix女士拥有凤凰城大学会计学理学学士学位。她也是东北大学D'Amore-McKim商学院的MBA候选人。
Lourdes Felix has served as a director of the Company since 2023. Lourdes Felix is a Hispanic entrepreneur and seasoned executive with over 30 years of experience in management, corporate finance, capital markets, public accounting, and the private sector including 15 years in executive leadership. She currently serves as CEO, CFO, and Director of BioCorRx Inc. (OTCQB: BICX), a biotechnology company specializing in addiction treatment solutions.A founding member and President of BioCorRx Pharmaceuticals Inc., she oversees commercialization and development of addiction and related disorder treatments, regulatory recruitment, strategic planning, and M&A activities. Lourdes led the launch of UnCraveRx, a weight loss program introduced in 2019, and in 2025, negotiated the company's acquisition of its first FDA approved drug, LUCEMYRA (lofexidine).Known for her strategic financial leadership, she has secured over $40 million in equity and non dilutive funding, and has extensive experience in SEC reporting, compliance, and risk management. Prior to BioCorRx, she worked in public accounting and the private sector, with deep expertise in GAAP, SEC, and SOX compliance, financial operations, and internal controls.Since 2023 to the present, Ms. Felix has served as a Board Member and Compensation Committee Chair of Avalon GloboCare Corporation (NASDAQ: ALBT), and from 2024 to the present as a Board Member and Audit Committee Chair of La Rosa Holdings Corp. (NASDAQ: LRHC). - Lourdes Felix，被任命为公司董事会成员，自2024年4月起生效。Felix女士是一位企业家和企业财务主管，在资本市场、公共会计和私营部门拥有30年的综合经验。她目前担任BioCorRx Inc.（OTCQB：BICX）的首席执行官、首席财务官以及董事会成员，该公司专注于成瘾治疗解决方案和相关疾病。自2012年10月起任职于BioCorRx。Felix女士是BioCorRx Pharmaceuticals Inc.的创始人之一和总裁，BioCorRx Pharmaceuticals Inc.是BioCorRx Inc.的控股子公司。在加入BioCorRx之前，她的工作经验是私营部门和公共会计。自2021年10月以来，Felix女士一直担任Siyata Mobile，Inc.（纳斯达克：SYTA）的董事会成员、独立董事、审计委员会主席以及薪酬委员会和提名与公司治理委员会成员。自2023年1月9日以来，Felix女士还一直担任Avalon GloboCare Corp.（纳斯达克：ALBT）的董事会成员、独立董事和薪酬委员会主席。Felix女士在财务、会计、全公司运营、预算编制和内部控制原则（包括GAAP、SEC和萨班斯-奥克斯利法案合规）方面拥有专长。她对联邦和州法规了如指掌，并成功管理和制作了SEC监管文件。她在发展和管理金融业务方面也有丰富的经验。Felix女士拥有凤凰城大学会计学理学学士学位。她也是东北大学D'Amore-McKim商学院的MBA候选人。
- Lourdes Felix has served as a director of the Company since 2023. Lourdes Felix is a Hispanic entrepreneur and seasoned executive with over 30 years of experience in management, corporate finance, capital markets, public accounting, and the private sector including 15 years in executive leadership. She currently serves as CEO, CFO, and Director of BioCorRx Inc. (OTCQB: BICX), a biotechnology company specializing in addiction treatment solutions.A founding member and President of BioCorRx Pharmaceuticals Inc., she oversees commercialization and development of addiction and related disorder treatments, regulatory recruitment, strategic planning, and M&A activities. Lourdes led the launch of UnCraveRx, a weight loss program introduced in 2019, and in 2025, negotiated the company's acquisition of its first FDA approved drug, LUCEMYRA (lofexidine).Known for her strategic financial leadership, she has secured over $40 million in equity and non dilutive funding, and has extensive experience in SEC reporting, compliance, and risk management. Prior to BioCorRx, she worked in public accounting and the private sector, with deep expertise in GAAP, SEC, and SOX compliance, financial operations, and internal controls.Since 2023 to the present, Ms. Felix has served as a Board Member and Compensation Committee Chair of Avalon GloboCare Corporation (NASDAQ: ALBT), and from 2024 to the present as a Board Member and Audit Committee Chair of La Rosa Holdings Corp. (NASDAQ: LRHC).
- Stuart D. Porter
-
Stuart D. Porter是DCM GP的唯一所有者和Denham IV GP的控股成员，并担任DCM的首席执行官和首席投资官。波特先生是美国公民。
Stuart D. Porter has served as a director of the Company since May 2026. Mr. Porter has over 29 years of senior investment experience, including as a Founder and Managing Partner of Denham Capital, where he currently serves as the Chief Executive Officer and Chief Investment Officer. Mr. Porter also serves on Denham Capital's Investment Committee and Valuation Committee. Prior to founding Denham Capital in 2004, Mr. Porter was a founding partner of Sowood Capital Management LP and, prior thereto, was employed as a Vice President and Portfolio Manager at Harvard Management Company, Inc., where he focused on public and private transactions in the energy and commodities sectors. Mr. Porter previously worked for Bacon Investments and at J. Aron, a division of Goldman Sachs. While at J. Aron, he worked on the Goldman Sachs Commodity Index desk. Prior to joining J. Aron, Mr. Porter was a self employed trader at the Chicago Board of Trade and was employed by Cargill Incorporated in Minnetonka, Minnesota in the Financial Markets Division. Mr. Porter received a Bachelor of Arts from the University of Michigan and a Master of Business Administration degree from the University of Chicago Booth School of Business. - Stuart D. Porter是DCM GP的唯一所有者和Denham IV GP的控股成员，并担任DCM的首席执行官和首席投资官。波特先生是美国公民。
- Stuart D. Porter has served as a director of the Company since May 2026. Mr. Porter has over 29 years of senior investment experience, including as a Founder and Managing Partner of Denham Capital, where he currently serves as the Chief Executive Officer and Chief Investment Officer. Mr. Porter also serves on Denham Capital's Investment Committee and Valuation Committee. Prior to founding Denham Capital in 2004, Mr. Porter was a founding partner of Sowood Capital Management LP and, prior thereto, was employed as a Vice President and Portfolio Manager at Harvard Management Company, Inc., where he focused on public and private transactions in the energy and commodities sectors. Mr. Porter previously worked for Bacon Investments and at J. Aron, a division of Goldman Sachs. While at J. Aron, he worked on the Goldman Sachs Commodity Index desk. Prior to joining J. Aron, Mr. Porter was a self employed trader at the Chicago Board of Trade and was employed by Cargill Incorporated in Minnetonka, Minnesota in the Financial Markets Division. Mr. Porter received a Bachelor of Arts from the University of Michigan and a Master of Business Administration degree from the University of Chicago Booth School of Business.
- Geordan Pursglove
-
Geordan PursGlove曾担任Beyond Commerce，Inc.的总裁、首席执行官和董事会主席。他还是Service 800，Inc.的总裁，Service 800，Inc.是一家领先的电话和在线客户满意度调查服务，向全球最知名的财富500强公司提供最具可操作性的客户反馈，他在其中领导运营、扩大收入并监督公司的战略愿景。Pursglove先生曾在SemiCab Holdings担任董事会职务，SemiCab Holdings是全球物流和分销行业的新兴领导者，隶属于Algorhythm Holdings（纳斯达克股票代码：RIME）。目前，Pursglove先生担任2GP Group LLC的董事总经理。在担任2GP集团董事总经理期间，Pursglove先生构建了体育、销售、营销和物流等多个业务。
Geordan Pursglove has served as a director of the Company since 2025. Prior to joining the Company, he served as President, Chief Executive Officer and Chairman of the Board of Beyond Commerce, Inc. (OTC PINK: BYOC). He was also President of Service 800 Inc., a leading phone and online customer satisfaction survey service that provided actionable customer feedback to Fortune 500 companies globally in which he led operations, scaled revenue and oversaw the company's strategic vision. He held a board position at SemiCab Holdings, an emerging leader in the global logistics and distribution industry that is a subsidiary of Algorhythm Holdings (NASDAQ: RIME). Mr. Pursglove also serves as Chief Executive Officer and a director of Powell Max Ltd (Nasdaq: PMAX). Additionally, he serves as the managing director of 2GP Group LLC where he built multiple businesses in sports, sales, marketing and logistics. Mr. Pursglove has over a decade of experience in M&A, public market space, capital raising, funding growth, scaling businesses and driving innovation. - Geordan PursGlove曾担任Beyond Commerce，Inc.的总裁、首席执行官和董事会主席。他还是Service 800，Inc.的总裁，Service 800，Inc.是一家领先的电话和在线客户满意度调查服务，向全球最知名的财富500强公司提供最具可操作性的客户反馈，他在其中领导运营、扩大收入并监督公司的战略愿景。Pursglove先生曾在SemiCab Holdings担任董事会职务，SemiCab Holdings是全球物流和分销行业的新兴领导者，隶属于Algorhythm Holdings（纳斯达克股票代码：RIME）。目前，Pursglove先生担任2GP Group LLC的董事总经理。在担任2GP集团董事总经理期间，Pursglove先生构建了体育、销售、营销和物流等多个业务。
- Geordan Pursglove has served as a director of the Company since 2025. Prior to joining the Company, he served as President, Chief Executive Officer and Chairman of the Board of Beyond Commerce, Inc. (OTC PINK: BYOC). He was also President of Service 800 Inc., a leading phone and online customer satisfaction survey service that provided actionable customer feedback to Fortune 500 companies globally in which he led operations, scaled revenue and oversaw the company's strategic vision. He held a board position at SemiCab Holdings, an emerging leader in the global logistics and distribution industry that is a subsidiary of Algorhythm Holdings (NASDAQ: RIME). Mr. Pursglove also serves as Chief Executive Officer and a director of Powell Max Ltd (Nasdaq: PMAX). Additionally, he serves as the managing director of 2GP Group LLC where he built multiple businesses in sports, sales, marketing and logistics. Mr. Pursglove has over a decade of experience in M&A, public market space, capital raising, funding growth, scaling businesses and driving innovation.
- Jason Sawyer
-
Jason Sawyer是另类投资行业30年的资深人士，也是总部位于拿骚的风险投资和咨询公司Access Alternative Group S.A.（AAG）的总经理。他居住在墨西哥坎昆，与领先的家族办公室和机构合作，在金融科技、生物技术、软件、能源和消费品等领域领导了超过2亿美元的早期和成长期投资。作为Crane Capital（出售给贝尔斯登）的一名负责人，他共同创立了Candlebrook Capital，并为包括Blackstone和Gottex在内的顶级管理公司筹集了超过35亿美元。他还共同创立并资助了Caary Capital、Pacific ST Stone、Sanna Health和California Fitness等公司，并获得了成功的退出和机构支持。他目前领导Quantum BioPharma（纳斯达克：QNTM）的财务和并购工作，并担任FUTR Corp（TSX.V：FTRC）的董事会成员。
Jason Sawyer has served as a director of the Company since 2025. Mr. Jason Sawyer is a 30 year veteran of the alternative investment industry and General Manager of Access Alternative Group S.A. (AAG), a Nassau based venture investment and advisory firm. Based in Cancún, Mexico, he has led over $200 million in early and growth stage investments across sectors including fintech, biotech, software, energy, and consumer products, partnering with leading family offices and institutions. Previously a Principal at Crane Capital (sold to Bear Stearns), he co founded Candlebrook Capital and has raised over $3.5 billion for top tier managers including Blackstone and Gottex. He has also co founded and financed companies such as Caary Capital, Pacific West Stone, Sanna Health, and California Fitness, with successful exits and institutional backing. He currently leads finance and M&A for Quantum BioPharma (Nasdaq: QNTM) and serves on the board of The FUTR Corp (TSX.V: FTRC). - Jason Sawyer是另类投资行业30年的资深人士，也是总部位于拿骚的风险投资和咨询公司Access Alternative Group S.A.（AAG）的总经理。他居住在墨西哥坎昆，与领先的家族办公室和机构合作，在金融科技、生物技术、软件、能源和消费品等领域领导了超过2亿美元的早期和成长期投资。作为Crane Capital（出售给贝尔斯登）的一名负责人，他共同创立了Candlebrook Capital，并为包括Blackstone和Gottex在内的顶级管理公司筹集了超过35亿美元。他还共同创立并资助了Caary Capital、Pacific ST Stone、Sanna Health和California Fitness等公司，并获得了成功的退出和机构支持。他目前领导Quantum BioPharma（纳斯达克：QNTM）的财务和并购工作，并担任FUTR Corp（TSX.V：FTRC）的董事会成员。
- Jason Sawyer has served as a director of the Company since 2025. Mr. Jason Sawyer is a 30 year veteran of the alternative investment industry and General Manager of Access Alternative Group S.A. (AAG), a Nassau based venture investment and advisory firm. Based in Cancún, Mexico, he has led over $200 million in early and growth stage investments across sectors including fintech, biotech, software, energy, and consumer products, partnering with leading family offices and institutions. Previously a Principal at Crane Capital (sold to Bear Stearns), he co founded Candlebrook Capital and has raised over $3.5 billion for top tier managers including Blackstone and Gottex. He has also co founded and financed companies such as Caary Capital, Pacific West Stone, Sanna Health, and California Fitness, with successful exits and institutional backing. He currently leads finance and M&A for Quantum BioPharma (Nasdaq: QNTM) and serves on the board of The FUTR Corp (TSX.V: FTRC).
- Michael Holloway
-
迈克尔·霍洛威是一位成就卓著的急诊内科医生和医疗事务主管。他在不列颠哥伦比亚省、艾伯塔省和安大略省的不同医疗保健环境中拥有丰富的经验。他在副总裁级别上展现了领导力和医疗创新。他在医疗保健等领域的政策制定、董事会治理和战略咨询方面有着良好的业绩记录。他还广泛接触包括医疗技术在内的多个领域的早期公司。自1999年以来，霍洛威博士一直担任弗雷泽和温哥华沿海卫生当局的急诊医学医生。2016年至今，他在不列颠哥伦比亚省温哥华的医疗器械公司Life 360 Innovations，Inc.担任医疗事务副总裁兼董事。自2000年至2019年，他担任不列颠哥伦比亚省急诊医学服务顾问。Holloway博士拥有阿尔伯塔大学、卡尔加里大学的医学博士、家庭实践住院医师、急诊医学专业。他获得了Stern Ontario大学Richard Ivey Biness学院的Biness Administration荣誉文学士学位。
Michael Holloway has served as a director of the Company since 2025. Dr. Holloway is an accomplished Emergency Medicine Physician and Medical Affairs executive. He has extensive experience spanning diverse healthcare environments across British Columbia, Alberta and Ontario. He has demonstrated leadership and medical innovation at Vice President level. He has a proven track record in policy development, board governance and strategic consulting in healthcare and oher fields. He also has extensive exposure to early stage companies in multiple fields, including med tech.Since 1999, Dr. Holloway has served as an Emergency Medicine Physician at Fraser and Vancouver Coastal Health Authorities. From 2016 to the present, he has served as the Vice President of Medical Affairs and Director at Life 360 Innovations, Inc. a medical device company in Vancouver, British Columbia. He served as an advisor for Emergency Medicine services for the province of British Columbia from 2000 2019. Dr. Holloway has a Doctor of Medicine, Family Practice Residency, Emergency Medicine Specialty from the University of Alberta, University of Calgary. He obtained an Honors Bachelor of Arts in Business Administration from the Richard Ivey School of Business, University of Western Ontario. - 迈克尔·霍洛威是一位成就卓著的急诊内科医生和医疗事务主管。他在不列颠哥伦比亚省、艾伯塔省和安大略省的不同医疗保健环境中拥有丰富的经验。他在副总裁级别上展现了领导力和医疗创新。他在医疗保健等领域的政策制定、董事会治理和战略咨询方面有着良好的业绩记录。他还广泛接触包括医疗技术在内的多个领域的早期公司。自1999年以来，霍洛威博士一直担任弗雷泽和温哥华沿海卫生当局的急诊医学医生。2016年至今，他在不列颠哥伦比亚省温哥华的医疗器械公司Life 360 Innovations，Inc.担任医疗事务副总裁兼董事。自2000年至2019年，他担任不列颠哥伦比亚省急诊医学服务顾问。Holloway博士拥有阿尔伯塔大学、卡尔加里大学的医学博士、家庭实践住院医师、急诊医学专业。他获得了Stern Ontario大学Richard Ivey Biness学院的Biness Administration荣誉文学士学位。
- Michael Holloway has served as a director of the Company since 2025. Dr. Holloway is an accomplished Emergency Medicine Physician and Medical Affairs executive. He has extensive experience spanning diverse healthcare environments across British Columbia, Alberta and Ontario. He has demonstrated leadership and medical innovation at Vice President level. He has a proven track record in policy development, board governance and strategic consulting in healthcare and oher fields. He also has extensive exposure to early stage companies in multiple fields, including med tech.Since 1999, Dr. Holloway has served as an Emergency Medicine Physician at Fraser and Vancouver Coastal Health Authorities. From 2016 to the present, he has served as the Vice President of Medical Affairs and Director at Life 360 Innovations, Inc. a medical device company in Vancouver, British Columbia. He served as an advisor for Emergency Medicine services for the province of British Columbia from 2000 2019. Dr. Holloway has a Doctor of Medicine, Family Practice Residency, Emergency Medicine Specialty from the University of Alberta, University of Calgary. He obtained an Honors Bachelor of Arts in Business Administration from the Richard Ivey School of Business, University of Western Ontario.
- Guy Primus
-
Guy Prim是一位成就卓著的高管和投资者，拥有领导跨技术、媒体和应用工程领域创新的丰富经验。Prim先生目前担任Thrillerdome的董事总经理，该公司是一家专注于创新战略、知识产权开发和商业化的咨询公司。从2020年到2023年，Prim先生担任Valence Enterprise的首席执行官，该公司是一家利用分析和数据智能来增强Biness连接的技术平台。从2014年到2020年，Prim先生担任虚拟现实公司的首席执行官，该公司是电影虚拟和增强现实领域的先驱，担任多元化媒体公司Overbrook Entertainment的首席运营官。Prim先生还曾是Keanry Management Consultants的顾问。Prim是一位发明家，拥有与基于情感的数据和er体验系统相关的多项专利。He previoly曾担任佐治亚理工大学工业与系统工程学院顾问委员会主席。普里姆先生在佐治亚理工学院获得了内部工程学士和硕士学位，并在哈佛大学比尼斯学院获得了MBA学位。
Guy Primus has served as a director of the Company since 2025. Mr. Primus is an accomplished executive and investor with extensive experience leading innovation across technology, media, and applied engineering. Mr. Primus is currently Managing Director of Thrillerdome, a consultancy focused on innovation strategy, intellectual property development, and commercialization.From 2020 to 2023, Mr. Primus was Chief Executive Officer of Valence Enterprise, a technology platform leveraging analytics and data intelligence to enhance business connectivity. From 2014 to 2020, Mr. Primus was Chief Executive Officer of The Virtual Reality Company, a pioneer in cinematic virtual and augmented reality as well as Chief Operating Officer of Overbrook Entertainment, a diversified media company. Mr. Primus also previously was a consultant with Keanry Management Consultants.Mr. Primus is an inventor credited with multiple patents related to emotion based data and user experience systems. He previously served as Chairman of the Advisory Board for the Georgia Tech School of Industrial and Systems engineering. Mr. Primus earned both his Bachelors and Master's Degree in Industrial Engineering from Georgia Tech and an MBA from Harvard Business School. - Guy Prim是一位成就卓著的高管和投资者，拥有领导跨技术、媒体和应用工程领域创新的丰富经验。Prim先生目前担任Thrillerdome的董事总经理，该公司是一家专注于创新战略、知识产权开发和商业化的咨询公司。从2020年到2023年，Prim先生担任Valence Enterprise的首席执行官，该公司是一家利用分析和数据智能来增强Biness连接的技术平台。从2014年到2020年，Prim先生担任虚拟现实公司的首席执行官，该公司是电影虚拟和增强现实领域的先驱，担任多元化媒体公司Overbrook Entertainment的首席运营官。Prim先生还曾是Keanry Management Consultants的顾问。Prim是一位发明家，拥有与基于情感的数据和er体验系统相关的多项专利。He previoly曾担任佐治亚理工大学工业与系统工程学院顾问委员会主席。普里姆先生在佐治亚理工学院获得了内部工程学士和硕士学位，并在哈佛大学比尼斯学院获得了MBA学位。
- Guy Primus has served as a director of the Company since 2025. Mr. Primus is an accomplished executive and investor with extensive experience leading innovation across technology, media, and applied engineering. Mr. Primus is currently Managing Director of Thrillerdome, a consultancy focused on innovation strategy, intellectual property development, and commercialization.From 2020 to 2023, Mr. Primus was Chief Executive Officer of Valence Enterprise, a technology platform leveraging analytics and data intelligence to enhance business connectivity. From 2014 to 2020, Mr. Primus was Chief Executive Officer of The Virtual Reality Company, a pioneer in cinematic virtual and augmented reality as well as Chief Operating Officer of Overbrook Entertainment, a diversified media company. Mr. Primus also previously was a consultant with Keanry Management Consultants.Mr. Primus is an inventor credited with multiple patents related to emotion based data and user experience systems. He previously served as Chairman of the Advisory Board for the Georgia Tech School of Industrial and Systems engineering. Mr. Primus earned both his Bachelors and Master's Degree in Industrial Engineering from Georgia Tech and an MBA from Harvard Business School.
- John Travaglini
-
John Travaglini自2026年5月起担任公司董事。Travaglini先生是一位技术和资本市场企业家，也是一位经验丰富的并购专业人士。他领导NOMAD Transportable Power Systems，同时担任4Front Capital Partners创始人，利用二十多年的时间建立公司、构建交易以及在公共和私人市场筹集资金。在创立4Front Capital Partners之前，John拥有一家位于多伦多的中型市场投资和商业银行咨询公司。在该职位上，他为全球大型跨国公司、基金和家族办公室提供财富保值、并购和国际投资方面的建议。在此之前，他共同拥有一家投资银行，在多伦多、伦敦、新加坡和澳大利亚悉尼设有办事处，完成的公开和私人交易总额超过2.5亿美元。在其职业生涯的早期，John co创立了一家系统集成公司，该公司的收入增长到超过5500万美元，他曾在Sun Microsystems和Unisys Corporation担任销售职位。此后，他在加拿大和国外的上市公司和私营公司担任董事会和执行管理职位。约翰拥有威尔弗里德·劳里埃大学的工商管理荣誉学位，毕业于毕马威会计师事务所和艾维商学院赞助的Quantum Shift Executive Management Program。
John Travaglini has served as a director of the Company since May 2026. Mr. Travaglini is a technology and capital markets entrepreneur and a highly experienced mergers and acquisitions professional. He leads NOMAD Transportable Power Systems alongside his role as founder of 4Front Capital Partners, drawing on more than two decades spent building companies, structuring transactions, and raising capital across public and private markets.Prior to founding 4Front Capital Partners, John owned a mid market investment and merchant banking consulting firm based in Toronto. In that role he advised large multinationals, funds, and family offices worldwide on wealth preservation, mergers and acquisitions, and international investments. Before that, he co owned an investment bank with offices in Toronto, London, Singapore, and Sydney, Australia, completing both public and private transactions totalling over $250 million.Earlier in his career, John co founded a systems integration company that grew to more than $55 million in revenue, and he held sales positions with Sun Microsystems and Unisys Corporation. He has since held board and executive management positions in both public and private companies in Canada and abroad.John holds an Honors Degree in Business Administration from Wilfrid Laurier University and is a graduate of the Quantum Shift Executive Management program sponsored by KPMG and the Ivey School of Business. - John Travaglini自2026年5月起担任公司董事。Travaglini先生是一位技术和资本市场企业家，也是一位经验丰富的并购专业人士。他领导NOMAD Transportable Power Systems，同时担任4Front Capital Partners创始人，利用二十多年的时间建立公司、构建交易以及在公共和私人市场筹集资金。在创立4Front Capital Partners之前，John拥有一家位于多伦多的中型市场投资和商业银行咨询公司。在该职位上，他为全球大型跨国公司、基金和家族办公室提供财富保值、并购和国际投资方面的建议。在此之前，他共同拥有一家投资银行，在多伦多、伦敦、新加坡和澳大利亚悉尼设有办事处，完成的公开和私人交易总额超过2.5亿美元。在其职业生涯的早期，John co创立了一家系统集成公司，该公司的收入增长到超过5500万美元，他曾在Sun Microsystems和Unisys Corporation担任销售职位。此后，他在加拿大和国外的上市公司和私营公司担任董事会和执行管理职位。约翰拥有威尔弗里德·劳里埃大学的工商管理荣誉学位，毕业于毕马威会计师事务所和艾维商学院赞助的Quantum Shift Executive Management Program。
- John Travaglini has served as a director of the Company since May 2026. Mr. Travaglini is a technology and capital markets entrepreneur and a highly experienced mergers and acquisitions professional. He leads NOMAD Transportable Power Systems alongside his role as founder of 4Front Capital Partners, drawing on more than two decades spent building companies, structuring transactions, and raising capital across public and private markets.Prior to founding 4Front Capital Partners, John owned a mid market investment and merchant banking consulting firm based in Toronto. In that role he advised large multinationals, funds, and family offices worldwide on wealth preservation, mergers and acquisitions, and international investments. Before that, he co owned an investment bank with offices in Toronto, London, Singapore, and Sydney, Australia, completing both public and private transactions totalling over $250 million.Earlier in his career, John co founded a systems integration company that grew to more than $55 million in revenue, and he held sales positions with Sun Microsystems and Unisys Corporation. He has since held board and executive management positions in both public and private companies in Canada and abroad.John holds an Honors Degree in Business Administration from Wilfrid Laurier University and is a graduate of the Quantum Shift Executive Management program sponsored by KPMG and the Ivey School of Business.
- Chris McKay
-
克里斯·麦凯曾担任NOMAD Transportable Power Systems，Inc.的首席运营官，该公司根据合并后成为公司的全资子公司，在分布式发电、可再生能源和储能方面拥有超过25年的经验。他的专长包括产品开发、产品管理、新业务开发。麦凯先生管理过与世界各地公用事业配电网络相连的数百个发电资产的系统车队。他直接与公用事业、投资者和商业/工业用户开发并执行合同。McKay先生拥有宾夕法尼亚大学化学工程学士学位。
Chris McKay has served as Chief Operating Officer of NOMAD Transportable Power Systems, Inc., which became as wholly owned subsidiary of the Company pursuant to the Merger, and has over 25 years of experience with distributed generation, renewables, and energy storage. His expertise includes product development, product management, and new business development. Mr. McKay has managed fleets of systems with hundreds of generation assets connected to utility distribution networks around the world. He has developed and executed contracts directly with utilities, investors, and commercial/industrial users. Mr. McKay holds a BS, Chemical Engineering from the University of Pennsylvania. - 克里斯·麦凯曾担任NOMAD Transportable Power Systems，Inc.的首席运营官，该公司根据合并后成为公司的全资子公司，在分布式发电、可再生能源和储能方面拥有超过25年的经验。他的专长包括产品开发、产品管理、新业务开发。麦凯先生管理过与世界各地公用事业配电网络相连的数百个发电资产的系统车队。他直接与公用事业、投资者和商业/工业用户开发并执行合同。McKay先生拥有宾夕法尼亚大学化学工程学士学位。
- Chris McKay has served as Chief Operating Officer of NOMAD Transportable Power Systems, Inc., which became as wholly owned subsidiary of the Company pursuant to the Merger, and has over 25 years of experience with distributed generation, renewables, and energy storage. His expertise includes product development, product management, and new business development. Mr. McKay has managed fleets of systems with hundreds of generation assets connected to utility distribution networks around the world. He has developed and executed contracts directly with utilities, investors, and commercial/industrial users. Mr. McKay holds a BS, Chemical Engineering from the University of Pennsylvania.
- Joaquin Aguerre
-
Joaquin Aguerre是PowerSecure，Inc.的战略投资组合开发总监，自2017年以来，他一直在推动该公司的储能解决方案方面发挥重要作用。凭借强大的工程背景和战略眼光，Aguerre先生擅长管理和开发推动可持续能源计划的混合微电网系统。Aguerre先生在担任现任职务之前曾担任过多个职务，包括在PowerSecure担任产品经理。他以这一身份在各种储能项目的开发和成功中发挥了关键作用，展示了他将技术专长与战略规划相融合的能力。他的职业生涯还包括在威德福国际公司和Amaro & Amaro工程解决方案公司做出重大贡献，在那里他担任过多个工程职位。Aguerre先生拥有Catolica de Cordoba大学的工程师学位，电气和电子工程。
Joaquin Aguerre is the Director of Strategic Portfolio Development at PowerSecure, Inc., where he has been instrumental in advancing the company's energy storage solutions since 2017. With a robust engineering background and a strategic vision, Mr. Aguerre excels in managing and developing hybrid microgrid systems that drive sustainable energy initiatives. Mr. Aguerre has served in many roles before stepping into his current role, including as a product manager at PowerSecure. In this capacity, he played a key role in the development and success of various energy storage projects, demonstrating his ability to blend technical expertise with strategic planning. His career also includes significant contributions at Weatherford International and Amaro & Amaro Engineering Solutions, where he held various engineering positions. Mr. Aguerre holds an Engineers Degree, Electrical and Electronics Engineering from Universidad Catolica de Cordoba. - Joaquin Aguerre是PowerSecure，Inc.的战略投资组合开发总监，自2017年以来，他一直在推动该公司的储能解决方案方面发挥重要作用。凭借强大的工程背景和战略眼光，Aguerre先生擅长管理和开发推动可持续能源计划的混合微电网系统。Aguerre先生在担任现任职务之前曾担任过多个职务，包括在PowerSecure担任产品经理。他以这一身份在各种储能项目的开发和成功中发挥了关键作用，展示了他将技术专长与战略规划相融合的能力。他的职业生涯还包括在威德福国际公司和Amaro & Amaro工程解决方案公司做出重大贡献，在那里他担任过多个工程职位。Aguerre先生拥有Catolica de Cordoba大学的工程师学位，电气和电子工程。
- Joaquin Aguerre is the Director of Strategic Portfolio Development at PowerSecure, Inc., where he has been instrumental in advancing the company's energy storage solutions since 2017. With a robust engineering background and a strategic vision, Mr. Aguerre excels in managing and developing hybrid microgrid systems that drive sustainable energy initiatives. Mr. Aguerre has served in many roles before stepping into his current role, including as a product manager at PowerSecure. In this capacity, he played a key role in the development and success of various energy storage projects, demonstrating his ability to blend technical expertise with strategic planning. His career also includes significant contributions at Weatherford International and Amaro & Amaro Engineering Solutions, where he held various engineering positions. Mr. Aguerre holds an Engineers Degree, Electrical and Electronics Engineering from Universidad Catolica de Cordoba.
高管简历
中英对照 | 中文 | 英文- Bas van der Baan
Bas van der Baan被任命为Lixte Biotechnology Holdings, Inc.董事会成员，自2022年6月17日起生效。自2023年9月26日起，范德班先生被任命为公司总裁兼首席执行官。自2023年10月6日起，由于约翰·科瓦奇博士去世，范德班先生也被任命为董事会主席。范德班先生在生物技术行业拥有20多年的经验，主要专注于肿瘤学和诊断学。他在管理化合物从临床开发到报销和商业化的过程中拥有广泛的专业知识，并与制药业、学术合作者、分销商、保险公司和政府建立伙伴关系，以成功推出新的肿瘤学产品。范德班先生最近担任Agendia的首席临床官，该公司是一家肿瘤分子诊断公司，总部位于加州欧文和阿姆斯特丹，任期至2023年7月15日。范德班先生是Tethis S.p.A.的独立董事。Tethis S.p.A.是一家位于米兰的新型液体活检测试平台开发商。范德班先生是2016年收购的液体活检公司ThromboDx、开发用于癌症治疗的合成致死药物组合的公司Qameleon Therapeutics和肿瘤药物开发公司Oncosence的联合创始人，该公司将衰老作为药物开发的目标。范德班先生的职业生涯始于1997年，他的职业生涯始于联合利华的一个特殊化学品部门，该部门后来被ICI收购。2002年，范德班先生加入了被徕卡收购的生物技术公司Kreatech，专门从事用于基因表达、DNA和蛋白质分析的生命科学试剂。范德班先生拥有荷兰瓦赫宁根大学的分子科学硕士学位。
Bas van der Baan was appointed to the Company's Board effective June 17, 2022. Effective, September 26, 2023, he replaced Jon Kovach as President and Chief Executive Officer and on October 6, 2023, he was appointed as Chairman of Board. Effective June 16,2025, he resigned as Chairman of the Board and Chief Executive Officer and on September 1,2025 as President. Mr. Van der Baan currently serves as Chief Scientific Officer of the Company.Mr. van der Baan has over 20 years of experience in the biotechnology industry, with a key foc on oncology and diagnostics. He has extensive knowhow in the process of managing a compound from clinical development to reimbursement and commercialization, as ll as the establishment of partnerships with the pharmaceutical industry, academic collaborators, distributors, insurance companies and governments to successfully launch new products. He was most recently the Chief Clinical Officer of Agendia, an oncology molecular diagnostic company through July 15,2023. He is an independent director of Tethis S.p.A., a Milan Italy based developer of a novel platform for liquid biopsy testing. He was co founder of ThromboDx, a liquid biopsy company that was acquired in 2016, Qameleon Therapeutics, a company developing synthetic lethal drug combinations for cancer treatment, and Oncosence, an oncology drug development company. He started his career in 1997 at a specialty chemicals division of Unilever. In 2002, he joined Kreatech, a biotechnology company that specialized in life science reagents for gene expression, DNA and protein analysis. He holds a master's degree in molecular sciences from the Wageningen University in the Netherlands.- Bas van der Baan被任命为Lixte Biotechnology Holdings, Inc.董事会成员，自2022年6月17日起生效。自2023年9月26日起，范德班先生被任命为公司总裁兼首席执行官。自2023年10月6日起，由于约翰·科瓦奇博士去世，范德班先生也被任命为董事会主席。范德班先生在生物技术行业拥有20多年的经验，主要专注于肿瘤学和诊断学。他在管理化合物从临床开发到报销和商业化的过程中拥有广泛的专业知识，并与制药业、学术合作者、分销商、保险公司和政府建立伙伴关系，以成功推出新的肿瘤学产品。范德班先生最近担任Agendia的首席临床官，该公司是一家肿瘤分子诊断公司，总部位于加州欧文和阿姆斯特丹，任期至2023年7月15日。范德班先生是Tethis S.p.A.的独立董事。Tethis S.p.A.是一家位于米兰的新型液体活检测试平台开发商。范德班先生是2016年收购的液体活检公司ThromboDx、开发用于癌症治疗的合成致死药物组合的公司Qameleon Therapeutics和肿瘤药物开发公司Oncosence的联合创始人，该公司将衰老作为药物开发的目标。范德班先生的职业生涯始于1997年，他的职业生涯始于联合利华的一个特殊化学品部门，该部门后来被ICI收购。2002年，范德班先生加入了被徕卡收购的生物技术公司Kreatech，专门从事用于基因表达、DNA和蛋白质分析的生命科学试剂。范德班先生拥有荷兰瓦赫宁根大学的分子科学硕士学位。
- Bas van der Baan was appointed to the Company's Board effective June 17, 2022. Effective, September 26, 2023, he replaced Jon Kovach as President and Chief Executive Officer and on October 6, 2023, he was appointed as Chairman of Board. Effective June 16,2025, he resigned as Chairman of the Board and Chief Executive Officer and on September 1,2025 as President. Mr. Van der Baan currently serves as Chief Scientific Officer of the Company.Mr. van der Baan has over 20 years of experience in the biotechnology industry, with a key foc on oncology and diagnostics. He has extensive knowhow in the process of managing a compound from clinical development to reimbursement and commercialization, as ll as the establishment of partnerships with the pharmaceutical industry, academic collaborators, distributors, insurance companies and governments to successfully launch new products. He was most recently the Chief Clinical Officer of Agendia, an oncology molecular diagnostic company through July 15,2023. He is an independent director of Tethis S.p.A., a Milan Italy based developer of a novel platform for liquid biopsy testing. He was co founder of ThromboDx, a liquid biopsy company that was acquired in 2016, Qameleon Therapeutics, a company developing synthetic lethal drug combinations for cancer treatment, and Oncosence, an oncology drug development company. He started his career in 1997 at a specialty chemicals division of Unilever. In 2002, he joined Kreatech, a biotechnology company that specialized in life science reagents for gene expression, DNA and protein analysis. He holds a master's degree in molecular sciences from the Wageningen University in the Netherlands.
- Geordan Pursglove
Geordan PursGlove曾担任Beyond Commerce，Inc.的总裁、首席执行官和董事会主席。他还是Service 800，Inc.的总裁，Service 800，Inc.是一家领先的电话和在线客户满意度调查服务，向全球最知名的财富500强公司提供最具可操作性的客户反馈，他在其中领导运营、扩大收入并监督公司的战略愿景。Pursglove先生曾在SemiCab Holdings担任董事会职务，SemiCab Holdings是全球物流和分销行业的新兴领导者，隶属于Algorhythm Holdings（纳斯达克股票代码：RIME）。目前，Pursglove先生担任2GP Group LLC的董事总经理。在担任2GP集团董事总经理期间，Pursglove先生构建了体育、销售、营销和物流等多个业务。
Geordan Pursglove has served as a director of the Company since 2025. Prior to joining the Company, he served as President, Chief Executive Officer and Chairman of the Board of Beyond Commerce, Inc. (OTC PINK: BYOC). He was also President of Service 800 Inc., a leading phone and online customer satisfaction survey service that provided actionable customer feedback to Fortune 500 companies globally in which he led operations, scaled revenue and oversaw the company's strategic vision. He held a board position at SemiCab Holdings, an emerging leader in the global logistics and distribution industry that is a subsidiary of Algorhythm Holdings (NASDAQ: RIME). Mr. Pursglove also serves as Chief Executive Officer and a director of Powell Max Ltd (Nasdaq: PMAX). Additionally, he serves as the managing director of 2GP Group LLC where he built multiple businesses in sports, sales, marketing and logistics. Mr. Pursglove has over a decade of experience in M&A, public market space, capital raising, funding growth, scaling businesses and driving innovation.- Geordan PursGlove曾担任Beyond Commerce，Inc.的总裁、首席执行官和董事会主席。他还是Service 800，Inc.的总裁，Service 800，Inc.是一家领先的电话和在线客户满意度调查服务，向全球最知名的财富500强公司提供最具可操作性的客户反馈，他在其中领导运营、扩大收入并监督公司的战略愿景。Pursglove先生曾在SemiCab Holdings担任董事会职务，SemiCab Holdings是全球物流和分销行业的新兴领导者，隶属于Algorhythm Holdings（纳斯达克股票代码：RIME）。目前，Pursglove先生担任2GP Group LLC的董事总经理。在担任2GP集团董事总经理期间，Pursglove先生构建了体育、销售、营销和物流等多个业务。
- Geordan Pursglove has served as a director of the Company since 2025. Prior to joining the Company, he served as President, Chief Executive Officer and Chairman of the Board of Beyond Commerce, Inc. (OTC PINK: BYOC). He was also President of Service 800 Inc., a leading phone and online customer satisfaction survey service that provided actionable customer feedback to Fortune 500 companies globally in which he led operations, scaled revenue and oversaw the company's strategic vision. He held a board position at SemiCab Holdings, an emerging leader in the global logistics and distribution industry that is a subsidiary of Algorhythm Holdings (NASDAQ: RIME). Mr. Pursglove also serves as Chief Executive Officer and a director of Powell Max Ltd (Nasdaq: PMAX). Additionally, he serves as the managing director of 2GP Group LLC where he built multiple businesses in sports, sales, marketing and logistics. Mr. Pursglove has over a decade of experience in M&A, public market space, capital raising, funding growth, scaling businesses and driving innovation.
- Peter Stazzone
Peter Stazzone是一名高级财务和BINCE开发主管，在初创企业、高增长和价值数十亿美元的组织中拥有超过20年的财务和运营管理经验。他是公共和非营利部门经验丰富的董事会成员。他在德保罗大学获得BINCE Administration（金融）硕士学位，在伊利诺伊大学获得理学学士学位（会计学）。他也是美国注册会计师协会会员。自2021年起至任职公司期间，他担任Beyond Commerce，Inc.的首席财务官，该公司是一家上市公司，经营BINEY至BINEY互联网营销技术和服务、电动汽车和物流市场。2016年至2021年，他是Strainz，Inc.的首席财务官，Strainz，Inc.是一家领先的大麻品牌和制造公司，在科罗拉多州、华盛顿州和内华达州开展业务。
Peter Stazzone Effective September 1, 2025, the Company appointed Peter Stazzone as Chief Financial Officer. Mr. Stazzone is a senior finance and business development executive with over 20 years of experience in finance and operations management within start ups, high growth and multi billion dollar organizations. He is an experienced board member in both public and non profit sectors. He earned his Master of Business Administration (Finance) from DePaul University and his Bachelor of Science (Accounting) from the University of Illinois. He is also a member of the American Institute of Certified Public Accountants. From 2021 to his appointment with the Company, he acted as the Chief Financial Officer of Beyond Commerce, Inc., a publicly traded company operating in the Business to Business Internet Marketing Technology and Services, electric vehicles and logistics markets. From 2016 to 2021, he was the Chief Financial Officer of Strainz, Inc., a leading cannabis brand and manufacturing company operating in Colorado, Washington and Nevada.- Peter Stazzone是一名高级财务和BINCE开发主管，在初创企业、高增长和价值数十亿美元的组织中拥有超过20年的财务和运营管理经验。他是公共和非营利部门经验丰富的董事会成员。他在德保罗大学获得BINCE Administration（金融）硕士学位，在伊利诺伊大学获得理学学士学位（会计学）。他也是美国注册会计师协会会员。自2021年起至任职公司期间，他担任Beyond Commerce，Inc.的首席财务官，该公司是一家上市公司，经营BINEY至BINEY互联网营销技术和服务、电动汽车和物流市场。2016年至2021年，他是Strainz，Inc.的首席财务官，Strainz，Inc.是一家领先的大麻品牌和制造公司，在科罗拉多州、华盛顿州和内华达州开展业务。
- Peter Stazzone Effective September 1, 2025, the Company appointed Peter Stazzone as Chief Financial Officer. Mr. Stazzone is a senior finance and business development executive with over 20 years of experience in finance and operations management within start ups, high growth and multi billion dollar organizations. He is an experienced board member in both public and non profit sectors. He earned his Master of Business Administration (Finance) from DePaul University and his Bachelor of Science (Accounting) from the University of Illinois. He is also a member of the American Institute of Certified Public Accountants. From 2021 to his appointment with the Company, he acted as the Chief Financial Officer of Beyond Commerce, Inc., a publicly traded company operating in the Business to Business Internet Marketing Technology and Services, electric vehicles and logistics markets. From 2016 to 2021, he was the Chief Financial Officer of Strainz, Inc., a leading cannabis brand and manufacturing company operating in Colorado, Washington and Nevada.